- Mesoblast ( NASDAQ: MESO ) announced that funds managed by Oaktree Capital Management have extended to Mesoblast the availability of up to an additional $30M of its $90M five year facility subject to achieving certain milestones on or before September 30, 2023.
- The company drew the first tranche of $60M in November 2021.
- The facility has a three-year interest only period, at a rate of 9.75% per annum, after which time 40% of the principal amortizes over two years and a final payment due November 2026.
For further details see:
Mesoblast and Oaktree extend availability of undrawn facility